ADAMTS13 recovery in caplacizumab-treated TTP

Blood. 2024 May 2;143(18):1785-1786. doi: 10.1182/blood.2024023862.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADAMTS13 Protein* / metabolism
  • Adult
  • Female
  • Humans
  • Male
  • Middle Aged
  • Purpura, Thrombotic Thrombocytopenic* / drug therapy
  • Single-Domain Antibodies / therapeutic use

Substances

  • ADAMTS13 Protein
  • ADAMTS13 protein, human
  • caplacizumab
  • Single-Domain Antibodies